We are live on ! Find out more
AKCA

Akcea Therapeutics Inc
AKCA

Delisted

AKCA was delisted on the 9th of October, 2020.

Back to rankings

62 hedge funds and large institutions have $704M invested in Akcea Therapeutics Inc in 2018 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more call options, than puts

Call options by funds: $13.1M | Put options by funds: $8.11M

38% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 16

5% less funds holding

Funds holding: 65 → 62 (-3)

14% less capital invested

Capital invested by funds: $817M → $704M (-$113M)

21% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 14

Holders
62
Holders Change
-3
Holders Change %
-4.62%
% of All Funds
1.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
22
Reduced
16
Closed
14
Calls
$13.1M
Puts
$8.11M
Net Calls
+$5.03M
Net Calls Change
+$33.1M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$14.7M
2
Citadel Advisors
Citadel Advisors
Florida
+$3.27M
3
BlackRock
BlackRock
New York
+$3.19M
4
First Trust Advisors
First Trust Advisors
Illinois
+$2.09M
5
MFAM
Motley Fool Asset Management
Virginia
+$1.46M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$18.4M
2
AA
ALPS Advisors
Colorado
-$5.31M
3
EC
EcoR1 Capital
California
-$3.23M
4
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
-$1.93M
5
Deutsche Bank
Deutsche Bank
Germany
-$1.06M
Name Holding Trade Value Shares
Change 		Change in
Stake
Legal & General Group
51
Legal & General Group
United Kingdom
$67K – – –
Canada Life
52
Canada Life
Manitoba, Canada
$60K – – –
AIP
53
Ameritas Investment Partners
Nebraska
$38K – – –
Daiwa Securities Group
54
Daiwa Securities Group
Japan
$20K +$8.41K +300 +82%
BNP Paribas Financial Markets
55
BNP Paribas Financial Markets
France
$10.1K -$11.4K -405 -55%
UBS Group
56
UBS Group
Switzerland
$6K -$81.9K -2,921 -94%
Bank of Montreal
57
Bank of Montreal
Ontario, Canada
$5K +$2.5K +89 +101%
CCA
58
Catalyst Capital Advisors
New York
$4K +$3.36K +120 New
TRCT
59
Tower Research Capital (TRC)
New York
$3K +$2.75K +98 New
QI
60
QS Investors
New York
$2K – – –
SIM
61
Sonora Investment Management
Arizona
$2K – – –
AA
62
ALPS Advisors
Colorado
– -$5.31M -151,688 Closed
PNC Financial Services Group
63
PNC Financial Services Group
Pennsylvania
– -$1.93M -55,144 Closed
SAM
64
Sectoral Asset Management
Quebec, Canada
– -$363K -10,356 Closed
Balyasny Asset Management
65
Balyasny Asset Management
Illinois
– -$303K -8,647 Closed
II
66
Ibex Investors
Colorado
– -$251K -7,170 Closed
Manulife (Manufacturers Life Insurance)
67
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$220K -6,291 Closed
QT
68
Quantbot Technologies
New York
– -$81K -2,313 Closed
OTC
69
Opera Trading Capital
France
– -$64K -1,818 Closed
CG
70
Cutler Group
California
– -$11.2K -400 Closed
BA
71
Ballew Advisors
Mississippi
– -$6K -245 Closed
Royal Bank of Canada
72
Royal Bank of Canada
Ontario, Canada
– -$4K -110 Closed
MAM
73
Meeder Asset Management
Ohio
– -$2K -66 Closed
WSTAM
74
Wilbanks Smith & Thomas Asset Management
Virginia
– -$1K -40 Closed
HMS
75
Hanseatic Management Services
New Mexico
– -$1K -35 Closed
1 2
3
4

AKCA Hedge Fund Activity: Q4 2018 in Review

62 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Akcea Therapeutics Inc (AKCA) for Q4 2018, worth a combined $704M — down 14% from $817M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of AKCA and 11 opened new positions — a net loss of 3 holders — while 16 trimmed existing stakes and 22 added.

The largest buyer was Fidelity Investments, adding an estimated $14.7M. The largest seller was Wellington Management Group, cutting an estimated $18.4M.

  • 62 institutional investors held Akcea Therapeutics Inc (AKCA) as of Q4 2018, down from 65 in Q3 2018.
  • Funds reported $704M of Akcea Therapeutics Inc stock for Q4 2018, down 14% quarter-over-quarter.
  • 11 funds opened new Akcea Therapeutics Inc positions in Q4 2018 and 14 closed out, a net change of -3 holders.
  • The largest Akcea Therapeutics Inc buyer in Q4 2018 was Fidelity Investments, an estimated $14.7M added.
  • The largest Akcea Therapeutics Inc seller in Q4 2018 was Wellington Management Group, an estimated $18.4M sold.

Based on aggregated 13F filings for Q4 2018.